Chime Financial, Inc.
CHYM Nasdaq Finance Services Financials FY2023–FY2025
Last close · Oct 23, 2026
$29.57
2.0%What Chime Financial, Inc. does
No business description yet.
- Legal name
- Chime Financial, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 6, 2026
- Accession · CIK
- 0001795586-26-000013
0001795586
Revenue and margins
Chime Financial, Inc. had $2.2B of revenue in fiscal 2025, up 30.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $32.9M in fiscal 2025, 1.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Chime Financial, Inc. returned $77.5M to shareholders in fiscal 2025, 236% of free cash flow. The diluted share count rose 264.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Chime Financial, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $240M | $707M | $1.1B |
| Current ratio | — | 3.4x | 4.5x |
| Quick ratio | — | 3.4x | 4.5x |
| Total assets | — | $1.5B | $2.0B |
| Total liabilities | — | $502M | $563M |
| Shareholders' equity | −$2.0B | −$1.9B | $1.4B |
| Net debt (− = net cash) | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | — | — | ✓ |
| Share count didn't rise | — | ✕ | ✕ |
| Gross margin rose | — | ✓ | ✓ |
| Revenue rose relative to assets | — | — | ✕ |
| F-score | — / 3 | — / 5 | 4 / 8 |
| Accruals ratio | — | −6.1% | −62.0% |
| Altman Z'' | — | −5.51 | −1.97 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $1.3B | $1.7B | $2.2B |
| Gross profit | $1.1B | $1.5B | $1.9B |
| Research and development | $259M | $310M | $935M |
| Operating income | −$236M | −$62.2M | −$1.0B |
| Pretax income | −$203M | −$22.7M | −$1.0B |
| Income tax | $0.2M | $2.6M | $0.8M |
| Net income | −$203M | −$25.3M | −$1.0B |
| Diluted EPS | −$3.22 | −$0.39 | −$4.27 |
| Diluted shares | 0.06B | 0.06B | 0.24B |
| Cash flow | |||
| Cash from operations | −$157M | $64.1M | $52.8M |
| Capital expenditure | $10.5M | $4.8M | $19.9M |
| Free cash flow | −$167M | $59.3M | $32.9M |
| Depreciation and amortization | $12.9M | $25.4M | $30.0M |
| Stock-based compensation | $26.0M | $29.8M | $1.1B |
| Acquisitions | $0.0M | $13.3M | $0.0M |
| Share buybacks | $0.1M | $1.0M | $77.5M |
| Dividends and buybacks | $0.1M | $1.0M | $77.5M |
| Balance sheet | |||
| Cash and short-term investments | $240M | $707M | $1.1B |
| Loans, net | — | $99.8M | $71.6M |
| Current assets | — | $1.3B | $1.8B |
| Current liabilities | — | $375M | $388M |
| Property and equipment, net | — | $92.7M | $94.3M |
| Goodwill | — | $27.5M | $27.5M |
| Intangible assets | — | — | $27.5M |
| Total assets | — | $1.5B | $2.0B |
| Total liabilities | — | $502M | $563M |
| Preferred stock | — | $0.0M | $0.0M |
| Shareholders' equity | −$2.0B | −$1.9B | $1.4B |
| Margins | |||
| Gross margin | 82.8% | 87.6% | 88.0% |
| Operating margin | −18.4% | −3.7% | −47.6% |
| EBITDA margin | −17.4% | −2.2% | −46.2% |
| Net margin | −15.9% | −1.5% | −46.2% |
| FCF margin | −13.1% | 3.5% | 1.5% |
| Returns | |||
| Return on capital employed | — | −5.7% | −66.0% |
| Return on assets | — | −1.7% | −59.0% |
| Return on tangible equity | — | — | −75.0% |
| Growth | |||
| Revenue growth | — | 30.9% | 30.7% |
| FCF growth | — | — | −44.6% |
| Share count change | — | 2.9% | 264.0% |
| Financial health | |||
| Current ratio | — | 3.4x | 4.5x |
| Quick ratio | — | 3.4x | 4.5x |
| Capital allocation | |||
| Capex / revenue | 0.8% | 0.3% | 0.9% |
| Stock comp / revenue | 2.0% | 1.8% | 49.0% |
| Payouts / FCF | — | 1.6% | 235.7% |
| Quality scores | |||
| Piotroski F-score | — | — | 4.0 |
| Altman Z'' | — | −5.5 | −2.0 |
| Accruals ratio | — | −6.1% | −62.0% |
Source: SEC EDGAR XBRL filings (CIK 0001795586). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
